-
Je něco špatně v tomto záznamu ?
Phosphorylation-dependent immunomodulatory properties of B.PAT polysaccharide isolated from Bifidobacterium animalis ssp. animalis CCDM 218
K. Pacyga-Prus, C. Sandström, D. Šrůtková, M. Schwarzer, S. Górska
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- bakteriální polysacharidy farmakologie chemie izolace a purifikace MeSH
- Bifidobacterium animalis * chemie MeSH
- buňky HT-29 MeSH
- Caco-2 buňky MeSH
- cytokiny metabolismus MeSH
- dendritické buňky účinky léků imunologie metabolismus MeSH
- fosforylace účinky léků MeSH
- imunologické faktory farmakologie chemie izolace a purifikace MeSH
- Lacticaseibacillus rhamnosus chemie MeSH
- lidé MeSH
- myši MeSH
- probiotika farmakologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
A wide range of articles describe the role of different probiotics in the prevention or treatment of various diseases. However, currently, the focus is shifting from whole microorganisms to their easier-to-define components that can confer similar or stronger benefits on the host. Here, we aimed to describe polysaccharide B.PAT, which is a surface antigen isolated from Bifidobacterium animalis ssp. animalis CCDM 218 and to understand the relationship between its structure and function. For this reason, we determined its glycerol phosphate-substituted structure, which consists of glucose, galactose, and rhamnose residues creating the following repeating unit: To fully understand the role of glycerol phosphate substitution on the B.PAT function, we prepared the dephosphorylated counterpart (B.MAT) and tested their immunomodulatory properties. The results showed that the loss of glycerol phosphate increased the production of IL-6, IL-10, IL-12, and TNF-α in bone marrow dendritic cells alone and after treatment with Lacticaseibacillus rhamnosus GG. Further studies indicated that dephosphorylation can enhance B.PAT properties to suppress IL-1β-induced inflammatory response in Caco-2 and HT-29 cells. Thus, we suggest that further investigation of B.PAT and B.MAT may reveal distinct functionalities that can be exploited in the treatment of various diseases and may constitute an alternative to probiotics.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018644
- 003
- CZ-PrNML
- 005
- 20241024111249.0
- 007
- ta
- 008
- 241015e20240718enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.carbpol.2024.122518 $2 doi
- 035 __
- $a (PubMed)39218543
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Pacyga-Prus, Katarzyna $u Laboratory of Microbiome Immunobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland. Electronic address: katarzyna.pacyga-prus@hirszfeld.pl
- 245 10
- $a Phosphorylation-dependent immunomodulatory properties of B.PAT polysaccharide isolated from Bifidobacterium animalis ssp. animalis CCDM 218 / $c K. Pacyga-Prus, C. Sandström, D. Šrůtková, M. Schwarzer, S. Górska
- 520 9_
- $a A wide range of articles describe the role of different probiotics in the prevention or treatment of various diseases. However, currently, the focus is shifting from whole microorganisms to their easier-to-define components that can confer similar or stronger benefits on the host. Here, we aimed to describe polysaccharide B.PAT, which is a surface antigen isolated from Bifidobacterium animalis ssp. animalis CCDM 218 and to understand the relationship between its structure and function. For this reason, we determined its glycerol phosphate-substituted structure, which consists of glucose, galactose, and rhamnose residues creating the following repeating unit: To fully understand the role of glycerol phosphate substitution on the B.PAT function, we prepared the dephosphorylated counterpart (B.MAT) and tested their immunomodulatory properties. The results showed that the loss of glycerol phosphate increased the production of IL-6, IL-10, IL-12, and TNF-α in bone marrow dendritic cells alone and after treatment with Lacticaseibacillus rhamnosus GG. Further studies indicated that dephosphorylation can enhance B.PAT properties to suppress IL-1β-induced inflammatory response in Caco-2 and HT-29 cells. Thus, we suggest that further investigation of B.PAT and B.MAT may reveal distinct functionalities that can be exploited in the treatment of various diseases and may constitute an alternative to probiotics.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a fosforylace $x účinky léků $7 D010766
- 650 12
- $a Bifidobacterium animalis $x chemie $7 D000069982
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a Caco-2 buňky $7 D018938
- 650 _2
- $a bakteriální polysacharidy $x farmakologie $x chemie $x izolace a purifikace $7 D011135
- 650 _2
- $a buňky HT-29 $7 D019073
- 650 _2
- $a probiotika $x farmakologie $7 D019936
- 650 _2
- $a dendritické buňky $x účinky léků $x imunologie $x metabolismus $7 D003713
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a imunologické faktory $x farmakologie $x chemie $x izolace a purifikace $7 D007155
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a Lacticaseibacillus rhamnosus $x chemie $7 D052201
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sandström, Corine $u Department of Molecular Sciences, Swedish University of Agricultural Sciences, Box 7015, SE-750 07 Uppsala, Sweden. Electronic address: corine.sandstrom@slu.se
- 700 1_
- $a Šrůtková, Dagmar $u Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic
- 700 1_
- $a Schwarzer, Martin $u Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic
- 700 1_
- $a Górska, Sabina $u Laboratory of Microbiome Immunobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland. Electronic address: sabina.gorska@hirszfeld.pl
- 773 0_
- $w MED00006149 $t Carbohydrate polymers $x 1879-1344 $g Roč. 344 (20240718), s. 122518
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39218543 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111243 $b ABA008
- 999 __
- $a ok $b bmc $g 2201505 $s 1230617
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 344 $c - $d 122518 $e 20240718 $i 1879-1344 $m Carbohydrate polymers $n Carbohydr Polym $x MED00006149
- LZP __
- $a Pubmed-20241015